# FDA recall D-0750-2021

> **Dr. Reddy's Laboratories, Inc.** · Class II · drug recall initiated 2021-07-19.

## Product

Tizanidine HCl Tablets, USP 4 mg, 150-count bottles, Rx only, Mfd By: Dr. Reddy's Laboratories limited, Srikakulam District, 532 409 INDIA, NDC 55111-180-15.

## Reason for recall

Failed Tablet/Capsule Specification: Some tablets are shaved

## Distribution

Nationwide within the United States

## Key facts

- **Recall number:** D-0750-2021
- **Recalling firm:** Dr. Reddy's Laboratories, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2021-07-19
- **Report date:** 2021-08-25
- **Termination date:** 2022-12-21

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Princeton, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0750-2021

## Citation

> AI Analytics. FDA recall D-0750-2021. Retrieved 2026-07-25 from https://api.ai-analytics.org/recall/D-0750-2021. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*